The clinical significance of ERCC1 in predicting the response to platinum-based chemoradiotherapy and prognosis of esophageal squamous cell carcinoma

ZHANG Xing,YANG Hao-xian,LUO Kong-jia,FU Jianhua

DOI: https://doi.org/10.3969/j.issn.1006-5725.2010.19.012

2010-01-01

Abstract:Objective To investigate the expression of ERCC1 in esophageal squamous cell carcinoma(ESCC),and to study the relationship between ERCC1 and the clinical pathologic characteristics and prognosis of ESCC patients who received chemoradiotherapy(CRT).Methods The expression of ERCC1 in ESCC was determined by immunohistochemistry(IHC).Results ERCC1 was highly expressed in 47(48.0%) patients and lowly expressed in 51(52.0%) patients.The level of ERCC1 was not correlated with clinical pathologic characteristics(All P > 0.05).The remission rate was 53.2% in ERCC1 higher-expressed group and was 58.8% in ERCC1 lower-expressed group(P = 0.575).In the definitive CRT group,the median overall survival of ERCC1 higher-expressed patients was 15 months,and that of ERCC1 lower-expressed patients was 21 months(P = 0.141).In the CRT followed by surgical group,the median overall survival of ERCC1 higher-expressed patients was 15 months,and that of ERCC1 lower-expressed patients was 41 months(P = 0.431).Conclusion The expression of ERCC1 may not be correlated with clinicopathologic factors,the response of ESCC to CRT,and prognosis.The predicting and prognostic significance of ERCC1 in ESCC should be further explored.